Health status of New Zealand European, Māori, and Pacific patients with diabetes in 242 New Zealand general practices

New Zealand Medical Journal

Volumn 119, Issue 1235, 2006, Pages

  Tomlin, Andrew M ^a   Tilyard, Murray W ^b   Dawson, Alexander G ^c   Dovey, Susan M ^d  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b Southlink Health   (New Zealand)

^c MINISTRY OF HEALTH   (New Zealand)

^d Best Practice Advocacy Centre   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; COOK ISLANDS; DATA ANALYSIS; DEMOGRAPHY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MAORI; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; PACIFIC ISLANDS; PATIENT CARE; PATIENT INFORMATION; RISK ASSESSMENT; SAMOA; SEX DIFFERENCE; SMOKING; VULNERABLE POPULATION; ABORIGINE; ADOLESCENT; BLOOD; CHILD; ETHNOLOGY; INFANT; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES COMPLICATIONS; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY PRACTICE; FEMALE; HEALTH STATUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT; MALE; MIDDLE AGED; NEW ZEALAND; OCEANIC ANCESTRY GROUP;

EID: 33745083083     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gudbjornsdottir S, Cederholm J, Nilsson P, Eliasson B. The National Diabetes Register in Sweden. Diabetes Care 2003;26:1270-6.
2. Morris AD, Boyle IR, MacAlpine R, et al. The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. BMJ. 1997;315:524-8.
3. Harris MF, Priddin D, Ruscoe W, et al. Quality of care provided by general practitioners using or not using division-based diabetes registers. Med J Aust. 2002;177:250-2.
4. Betz Brown J, Nichols GA. Case-control study of 10 years of comprehensive diabetes care. West J Med. 2000;172:85-90.
5. Davis ME, Cull CA, Holman RR. Relationship between ethnicity and glycaemic control, lipid profiles, and blood pressure during the first 9 years of Type 2 diabetes. Diabetes Care. 2001;24:1167-74.
6. De Rekeneire N, Rooks RN, Simonsick EM, et al. Racial differences in glycemic control in a well-functioning older diabetic population: findings from the Health, Aging and Body Composition study. Diabetes Care. 2003;26:1986-92.
7. Pacy PJ, Dodson PM, Kubicki AJ, Fletcher RF. Differences in lipid and lipoprotein levels in white, black and Asian non-insulin dependent (type 2) diabetics with hypertension. Diabetes Res. 1987;4:187-93.
8. Leicester Royal Infirmary, U.K. A comparison of the clinical features and vascular complications of diabetes between migrant Asians and Caucasians in Leicester, U.K. Diabetes Res Clin Pract. 1991;14:205-13.
9. Ismail IS, Nazaimoon W, Mahamad W, et al. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia. Diabet Med. 2001;18:501-8.
10. Health Funding Authority. Diabetes 2000. Wellington; Government Printer; 2000.
11. Ministry of Health. Modelling Diabetes: A Summary. Public Health Intelligence Occasional Bulletin No 11. Wellington: MOH; 2002.
12. Liebl A, Mata M, Eschwege E. Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia. 2002,45:S23-8.
13. Management of Diabetes: A national clinical guideline. Edinburgh: Scottish Intercollegial Guidelines Network; 2001.
14. Fox CS, Sullivan L, D'Agostino RB Sr, Wilson PW. The Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality: The Framingham Heart Study. Diabetes Care. 2004;27:704-8.
15. Dinneen SF, Bjornsen SS, Bryant SC, et al. Towards an optimal model for community-based diabetes care: design and baseline data from the Mayo Health System Diabetes Translation Project. J Eval Clin Pract. 2000;6:421-9.
16. Coppell K, Manning P. Establishing a regional diabetes register and a description of the registered population after one year. N Z Med J. 2002;115(1160). URL: http://www.nzma.org.nz/journal/115-1160/146/